Bio-Rad Labs Inc. A buy UBS Group AG
Start price
07.12.23
/
50%
€285.60
Target price
07.12.24
€365.97
Performance (%)
-8.30%
Price
10.05.24
€261.90
Summary
This prediction is currently active. With a performance of -8.30%, the BUY prediction for Bio-Rad Labs Inc. A by UBS_Group_AG is down slightly. This prediction currently runs until 07.12.24. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Bio-Rad Labs Inc. A | 0.615% | 0.615% |
| iShares Core DAX® | 4.094% | 4.888% |
| iShares Nasdaq 100 | 1.424% | -0.445% |
| iShares Nikkei 225® | -1.572% | -4.911% |
| iShares S&P 500 | 1.822% | 0.776% |
Comments by UBS_Group_AG for this prediction
In the thread Bio-Rad Labs Inc. A diskutieren
Bio-Rad Laboratories, Inc. (NYSE: BIO) is now covered by analysts at UBS Group AG. They set a "buy" rating and a $395.00 price target on the stock.
Ratings data for BIO provided by MarketBeat
Stopped prediction by UBS_Group_AG for Bio-Rad Labs Inc. A
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€248.20
08.05.24
08.05.24
€357.93
08.05.25
08.05.25
5.52%
10.05.24
10.05.24
Bio-Rad Labs Inc. A
Start price
Target price
Perf. (%)
€316.20
16.02.24
16.02.24
€389.51
16.02.25
16.02.25
-17.17%
10.05.24
10.05.24